Franklin Resources’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Franklin Resources’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-273,810	Closed	-$29.4M	–	2789
2023 Q1	$29.4M	Sell	273,810 -188,038	-41%	-$21.6M	0.01%	673
2022 Q4	$50.8M	Sell	461,848 -66,789	-13%	-$4.33M	0.03%	525
2022 Q3	$31.2M	Buy	528,637 +66	+0%	+$3.02K	0.02%	656
2022 Q2	$14.9M	Buy	528,571 +172	+0%	+$4.99K	0.01%	866
2022 Q1	$20M	Sell	528,399 -28,701	-5%	-$1.13M	0.01%	855
2021 Q4	$22M	Hold	557,100	–	–	0.01%	868
2021 Q3	$13.2M	Hold	557,100	–	–	0.01%	994
2021 Q2	$13.7M	Sell	557,100 -52,704	-9%	-$1.18M	0.01%	957
2021 Q1	$11.1M	Buy	+609,804	New	+$12.6M	﹤0.01%	954

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Franklin Resources's RXDX Position: Q2 2023 in Review

Franklin Resources sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 273,810 shares — an estimated $29.4M sold.

Franklin Resources first reported a position in RXDX in Q1 2021 and held it in 9 quarters. The position peaked at $50.8M in Q4 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Franklin Resources reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Franklin Resources sold 273,810 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $29.4M.
Franklin Resources first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Franklin Resources's Prometheus Biosciences, Inc. Common Stock position peaked at $50.8M in Q4 2022.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Franklin Resources's 13F filing for Q2 2023, filed 11 Aug 2023.